Gpi-anchored cytokines

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 48/00 (2006.01) C12N 5/0783 (2010.01) A61K 31/7088 (2006.01) A61K 38/20 (2006.01) A61K 39/00 (2006.01) A61P 35/00 (2006.01) A61P 37/04 (2006.01) C07K 14/55 (2006.01) C12N 15/19 (2006.01) C12N 15/861 (2006.01)

Patent

CA 2458236

The present invention relates to immunogenic compositions for stimulating T cell proliferation and methods for enhancing therapeutic effectiveness of some traditional anti-cancer treatments. Specifically, local delivery of cytokines that target the plasma membrane of a cancerous cell exhibit more potent anti- tumor effects than systemic delivery of cytokines in soluble form. Figure 2 shows pulmonary metastasis images of untreated tumor cells with tumor cells treated with soluble IL-2 and tumor cells treated with GPI anchored IL-2.

La présente invention concerne des compositions immunogènes stimulant la prolifération des lymphocytes T, et des procédés renforçant l'efficacité de certains traitements anticancéreux. Plus particulièrement, l'apport local des cytokines ciblant la membrane plasmatique d'une cellule cancéreuse donne de meilleurs résultats antitumoraux que l'apport systémique de cytokines sous forme soluble.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Gpi-anchored cytokines does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Gpi-anchored cytokines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Gpi-anchored cytokines will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1966684

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.